Bayforest Capital’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TVTX
Bayforest Capital's TVTX Position: Q3 2026 in Review
Bayforest Capital opened a new position in Travere Therapeutics (TVTX) in Q3 2026: 894 shares worth $52.6K. The stake represents 0.08% of the portfolio and ranks #473 among its holdings. This is a return to the name: Bayforest Capital previously reported a position in TVTX as recently as Q1 2026.
Bayforest Capital first reported a position in TVTX in Q1 2026 and has held it in 2 quarters since. The position peaked at $104K in Q1 2026. 251 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.
- Bayforest Capital held 894 shares of Travere Therapeutics worth $52.6K as of Q3 2026.
- Travere Therapeutics was a new Bayforest Capital position in Q3 2026.
- Travere Therapeutics made up 0.08% of Bayforest Capital's portfolio in Q3 2026, its #473 holding.
- Bayforest Capital first reported a position in Travere Therapeutics in Q1 2026 and has held it in 2 quarters since.
- Bayforest Capital's Travere Therapeutics position peaked at $104K in Q1 2026.
- 251 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.
Based on Bayforest Capital's 13F filing for Q3 2026, filed 3 Nov 2026.